Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or

Biostar Pharmaceutic (BSPM) NASDAQ

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview as of [[ item.timeDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
3-Month Performance
View Chart

Fundamentals

See More
  • Market Capitalization, $K 8,460
  • Shares Outstanding, K 2,640
  • Annual Sales, $ 27,130 K
  • Annual Income, $ -25,110 K
  • 36-Month Beta 1.92
  • Price/Sales 0.31
  • Price/Book 0.20

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.94 +7.14%
on 11/10/16
3.93 -19.85%
on 11/25/16
+0.16 (+5.35%)
since 11/09/16
3-Month
2.02 +55.94%
on 09/13/16
7.06 -55.38%
on 10/11/16
+1.12 (+55.17%)
since 09/09/16
52-Week
1.08 +191.67%
on 05/19/16
7.06 -55.38%
on 10/11/16
-0.63 (-16.67%)
since 12/09/15

Most Recent Stories

More News
Drug Makers Stocks on Investors' Radar -- Immune Pharma, Sanofi, Biostar Pharma, and Shire

Pre-market, Stock-Callers.com follows the performances of four major players in the Drug Manufacturers space: Immune Pharmaceuticals Inc. (NASDAQ: IMNP), Sanofi (NYSE: SNY), Biostar Pharmaceuticals Inc....

Biostar Pharmaceuticals Completes Previously Announced Registered Direct Financing

Biostar Pharmaceuticals, Inc. (NASDAQ:BSPM) ("Biostar"), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in China, announced today that it completed the sale of 425,000...

Research Reports Initiation on Healthcare Stocks -- Alimera Sciences, Biostar Pharma, LifePoint Health, and Quorum Health

Stock-Callers.com is currently reviewing the most recent performances of the following equities: Alimera Sciences Inc. (NASDAQ: ALIM), Biostar Pharmaceuticals Inc. (NASDAQ: BSPM), LifePoint Health Inc....

Biostar Announces Execution of Agreement for $1.91 Million Registered Direct Offering of Shares of Common Stock and Warrants

Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) ("Biostar" or "the Company"), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in China, announced today that it entered...

Biostar to Launch a New Product Aimed at Treating Effects of Rhinitis and Sinusitis

Biostar Pharmaceuticals, Inc. (BSPM) ("Biostar"), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in China for a variety of diseases and conditions, today announced...

Biostar Pharmaceuticals Signs a Letter of Intent to Acquire Xianyang Yongsheng Health Products Co., Ltd.

Biostar Pharmaceuticals, Inc. (BSPM) ("Biostar" or "the Company"), a PRC-based manufacturer of pharmaceutical and health supplement products, and Xianyang Yongsheng Health Products Co., Ltd., a privately...

Biostar Pharmaceuticals, Inc. Announces Its Quarterly Results for Three Months Ended June 30, 2016

Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) ("Biostar" or "the Company"), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in China for a variety of diseases and...

Global Liver Cancer Pipeline Review, H2 2015 - 150+ Companies & Drug Profiles

Research and Markets (http://www.researchandmarkets.com/research/5j6swm/liver_cancer) has announced the addition of the "Liver Cancer - Pipeline Review, H2 2015" report to their offering. This report...

BUYINS.NET: BSPM SqueezeTrigger Price is $2.06. There is $17,430 That Short Sellers Still Need To Cover.

BUYINS.NET / www.squeezetrigger.com is monitoring Biostar Pharmaceuticals Inc (NASDAQ:BSPM) in real time and just received an alert that BSPM is crossing above its primary SqueezeTrigger Price, the price...

Biostar Pharmaceuticals to Effect Reverse Stock Split

Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) ("Biostar" or "the Company"), a PRC-based developer, manufacturer and marketer of pharmaceutical and health supplement products in China, today announced that...

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators mostly agree with the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More

Business Summary

BioStar Pharmaceuticals, Inc., through its wholly-owned subsidiary, Shaanxi Aoxing Pharmaceutical Co., Ltd., develops, manufactures and markets pharmaceutical and medical nutrient products for a variety of diseases and conditions. The Company's most popular product is its Xin Ao Xing Oleanolic Acid Capsule,...

See More

Support & Resistance

2nd Resistance Point 3.25
1st Resistance Point 3.19
Last Price 3.30
1st Support Level 3.09
2nd Support Level 3.05

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.